1White WB,Morganroth J.Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy[J].Am J Cardiol.1989,63(1):94-98.
2Corman B,Vienet R.Converting enzyme inhibition prevents postprandial hyperfilteration in rats with renal mass ablation[J].Am J Hypertens,1991.(3pt2):S253-S257.
3Erley CM,Bader B,Seheu M,et al.Renal haemodynamics in essential hypertensives treated with Losartan[J].Clin Nephrol.1995,43(Suppl 1):S8-S11.
4Burnier M,Rutschmann B,Nussberger J,et al.Salt-dePendent renal effects of an angiotensinⅡantagonist in healthy subjects[J].Hypertension,1993,22(3):339-347.
5Hahimoto E, Ogita T, Nakaoka T, et al. Rapid induction of vascular endothelial growth factor expression by transient ischemica in rat heart[J]. Am J Physiol, 1994,267(4) : 1948-1954.
6Neufeld G, Tzafra Cohen, Stela Gengrinovitch, et al. Vascular endothelial growth factor (VEGF)and its receptors[J]. FASEB J, 1999,13(1) :9-22.
7Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of vascular endothelial growth factor family[J] . Cardiovasc Res ,2001,49:568-581 .
8Salvador moncada. The L-arginine Nitric Oxide pathway [J].NEJM, 1993,329(27) :2002-2012.
9Hayashida W. Itracellalar-thard loop domain of angiotensin Ⅱ type 2 receptor rol in cellular signal transduction and functional expression [ J ]. J Biol Chem, 1996,271 (36) : 21985-21992.
10Zachary I. Signaling transduction mechanisms mediating vascular protective actions of vascular endothelial growth factor[J]. Am J Physiol Cell Physiol, 2001,280(6) : 1375-1386.
